Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
March 20, 2007
By: Tim Wright
Thermo Fisher Scientific has signed a joint venture agreement with the Gerresheimer Group to create a business that manufactures disposable and reusable glass labware for scientific labs. Gerresheimer is a global supplier of specialty glass and plastic devices for life sciences markets. The new business, called Kimble/Chase Life Scienceware, LLC, will be based in NJ, with additional operations in the U.S., Germany, Mexico and China. The closing of the joint venture is subject to customary closing conditions and applicable regulatory approvals. Under the agreement, Thermo Fisher will own 49% of the joint venture, contributing its Chase Scientific, Scherf and Pfeiffer glassware lines manufactured in the U.S. and Germany. Gerresheimer will own 51% and contribute its life science research products including certain Kimble, Kontes and Bomex brands manufactured in the U.S., Mexico and China. Combined, these products generated sales of approximately $123 million in 2006. The agreement expands an existing sales and marketing joint venture that was established in 2001. “This joint venture will reshape the glass consumables marketplace,” said Guy Broadbent, senior vice president and president of laboratory products for Thermo Fisher Scientific. “The combination of well-known glass labware brands from Thermo Fisher and Gerresheimer will form a leading supplier with an extensive product portfolio and a global footprint. With its significant production capabilities in China, the new business will be able to more effectively deliver its products to customers in that growing market as well as other parts of the world.” Dr. Axel Herberg, president and chief executive officer of the Gerresheimer Group, said, “This combination of mutual strengths marks an important step in the logical expansion of our businesses in the highly specialized pharma and life science markets. Through the formation of this joint venture, we will gain new dynamism in an important market segment of life science research.”
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !